Judge Boots Investor Class Action Over Feraheme Risks
By Roxanne Palmer ( August 15, 2011, 5:02 PM EDT) -- A Massachusetts federal judge on Thursday tossed a putative class action brought by AMAG Pharmaceuticals Inc. shareholders against the company and its underwriters for allegedly misleading investors about the risks associated with AMAG's injectable iron deficiency treatment Feraheme....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.